Latest news
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Business WireBusiness Wire · Fri, 07 Aug 2026 20:30:00 GMTDr Akkus on the Second-Line Evidence Gap in Advanced HCC - OncLiveOncLive · Fri, 07 Aug 2026 20:20:25 GMTDostarlimab Monotherapy Elicits Responses in First-Line PD-L1-Positive HNSCC - OncLiveOncLive · Fri, 07 Aug 2026 15:25:50 GMTFull Data Published Showing 87% CR at 3 Years for Epcoritamab Plus BR in First-Line FL - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Thu, 06 Aug 2026 21:38:09 GMTRights group warns Israel’s policies are pushing the West Bank healthcare system to collapse - Boston HeraldBoston Herald · Thu, 06 Aug 2026 15:26:32 GMTNICE Expands First-Line Options for Two Blood Cancers - MedscapeMedscape · Thu, 06 Aug 2026 11:51:08 GMTNICE recommends new treatment for Mantle Cell Lymphoma and Chronic Lymphocytic Leukaemia - National Health ExecutiveNational Health Executive · Thu, 06 Aug 2026 09:32:12 GMTNavigating Second-Line Treatments in 2026 CSU Guidelines, With Adam Friedman, MD - HCPLiveHCPLive · Wed, 05 Aug 2026 21:04:50 GMT